Dr Adam Stewart
Dr

Adam Stewart

Email: 

Background

Adam G. Stewart, BBiomedSci, MBBS(Hons), MPHTM, MBiostat, FRACP, FRCPA, PhD

Dr Adam Stewart is is an Australian-trained Infectious Diseases Physician and Clinical Microbiologist. He is currently working on clinical faculty as an Assistant Professor at the University of Texas MD Anderson Cancer Center in Houston, USA. He has previously undertaken post-fellowship subspeciality training in Transplant Infectious Diseases at Massachusetts General Hospital and Harvard University. Dr Stewart is an active physician-scientist with interests in clinical trials, invasive fungal disease, and infections in oncology and transplant patients. Dr Stewart is committed to advancing the management of infections in cancer patients.

Availability

Dr Adam Stewart is:
Available for supervision
Media expert

Qualifications

  • Bachelor of Biomedical Science, Griffith University
  • Bachelor of Medicine and Surgery and Medical Science, Griffith University
  • Masters (Coursework) of Public Health and Tropical Medicine, James Cook University

Research interests

  • Invasive fungal disease

    Clinical and translational research on the causes of early treatment failure and refractory infection in haematological malignancy patients

  • Fungal diagnostics

    Fungal pathogenesis research; host and pathogen biomarker discovery for clinical use for diagnostic and prognostic purposes

  • Clinical trials

    Novel clinical trial design for rare or uncommon pathogens including those causing invasive fungal disease

Search Professor Adam Stewart’s works on UQ eSpace

105 works between 2015 and 2026
All (105) Journal Article (102) Other Outputs (1) Conference Publication (2)

101 - 105 of 105 works

2018

Journal Article

Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program

Stewart, A., Roberts, J. A., Wallis, S. C., Allworth, A. M., Legg, A. and McCarthy, K. L. (2018). Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program. International Journal of Antimicrobial Agents, 51 (6), 941-942. doi: 10.1016/j.ijantimicag.2018.02.008

Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program

2017

Journal Article

Rickettsia Australis and Queensland tick typhus: a rickettsial spotted fever group infection in Australia

Stewart, Adam, Armstrong, Mark, Graves, Stephen and Hajkowicz, Krispin (2017). Rickettsia Australis and Queensland tick typhus: a rickettsial spotted fever group infection in Australia. American Journal of Tropical Medicine and Hygiene, 97 (1), 24-29. doi: 10.4269/ajtmh.16-0915

Rickettsia Australis and Queensland tick typhus: a rickettsial spotted fever group infection in Australia

2017

Journal Article

Clinical manifestations and outcomes of Rickettsia australis infection: a 15-year retrospective study of hospitalized patients

Stewart, Adam, Armstrong, Mark, Graves, Stephen and Hajkowicz, Krispin (2017). Clinical manifestations and outcomes of Rickettsia australis infection: a 15-year retrospective study of hospitalized patients. Tropical Medicine and Infectious Disease, 2 (2) 19, 19. doi: 10.3390/tropicalmed2020019

Clinical manifestations and outcomes of Rickettsia australis infection: a 15-year retrospective study of hospitalized patients

2017

Journal Article

Epidemiology and characteristics of Rickettsia australis (Queensland tick typhus) infection in hospitalized patients in North Brisbane, Australia

Stewart, Adam, Armstrong, Mark, Graves, Stephen and Hajkowicz, Krispin (2017). Epidemiology and characteristics of Rickettsia australis (Queensland tick typhus) infection in hospitalized patients in North Brisbane, Australia. Tropical Medicine and Infectious Disease, 2 (2) 10, 10. doi: 10.3390/tropicalmed2020010

Epidemiology and characteristics of Rickettsia australis (Queensland tick typhus) infection in hospitalized patients in North Brisbane, Australia

2015

Journal Article

The use of therapeutic drug monitoring to optimize treatment of carbapenem-resistant enterobacter osteomyelitis

Stewart, Adam, Graves, Bianca, Hajkowicz, Krispin, Ta, Kim and Paterson, David L. (2015). The use of therapeutic drug monitoring to optimize treatment of carbapenem-resistant enterobacter osteomyelitis. Microbial Drug Resistance, 21 (6), 631-635. doi: 10.1089/mdr.2015.0006

The use of therapeutic drug monitoring to optimize treatment of carbapenem-resistant enterobacter osteomyelitis

Past funding

  • 2020 - 2022
    Assessing in vitro activity of oral third generation cephalosporin / beta-lactamase inhibitor combinations against extended spectrum beta-lactamase (ESBL) producing uropathogens
    The Royal College of Pathologists of Australasia
    Open grant
  • 2020 - 2021
    USE OF THERAPEUTIC DRUG MONITORING (TDM) TO OPTIMISE ORAL/ENTERAL HYDROXYCHLOROQUINE DOSING IN CRITICALLY ILL PATIENTS WITH COVID-19 (MRFF CRR Respiratory Medicine administered by QUT)
    Queensland University of Technology
    Open grant
  • 2020 - 2025
    COVID-19 Cure Research (Paterson)
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on gut microbiota of hospitalized patients
    Avant Mutual Group Limited
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on the gut microbiome of hospitalized patients
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2022
    A Multicentre, Parallel Group Open-label Randomised Controlled Non-Inferiority Phase 3 Trial, of ceftolozane-tazobactam versus meropenem for definitive treatment [...] MERINO-3
    Merck Sharp & Dohme Australia
    Open grant
  • 2018 - 2021
    A multicentre, Parallel Group Open-label RC Non-Inferiority Trial of piperacillin-tazobactam versus meropenem for definitive treatment of bloodstream infection due to AmpC-producing Enterobacterales
    Junior Doctor Research Fellowships
    Open grant

Availability

Dr Adam Stewart is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Enquiries

Contact Dr Adam Stewart directly for media enquiries about:

  • clinical trial
  • infectious diseases
  • superbugs

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au